carvedilol has been researched along with Abnormality, Heart in 9 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "The effect of carvedilol on heart failure (HF) in patients with a functionally univentricular heart (UVH) remains unclear." | 7.77 | Effect of carvedilol on heart failure in patients with a functionally univentricular heart. ( Ando, M; Doi, S; Ishibashi, N; Mimori, S; Mizutani, S; Mori, K; Murakami, Y; Nakanishi, T; Park, IS; Takahashi, Y; Waragai, T; Yoshikawa, T, 2011) |
| "Carvedilol was initiated at a dose of 0." | 6.74 | Efficacy and safety of carvedilol for heart failure in children and patients with congenital heart disease. ( Ando, M; Hatai, Y; Mori, K; Murakami, Y; Nishiyama, M; Park, IS; Takahashi, Y; Yoshikawa, T, 2009) |
| " Studies investigating any of three beta blockers (carvedilol, bisoprolol, and extended release metoprolol succinate) which are known to be effective in adult patients with heart failure were included." | 4.91 | Effects of beta-blockers for congestive heart failure in pediatric and congenital heart disease patients: a meta-analysis of published studies. ( Cho, MJ; Jung Kwak, M; Kim, HY; Kim, YM; Lee, HD; Lim, RK; Park, KH, 2015) |
| "The effect of carvedilol on heart failure (HF) in patients with a functionally univentricular heart (UVH) remains unclear." | 3.77 | Effect of carvedilol on heart failure in patients with a functionally univentricular heart. ( Ando, M; Doi, S; Ishibashi, N; Mimori, S; Mizutani, S; Mori, K; Murakami, Y; Nakanishi, T; Park, IS; Takahashi, Y; Waragai, T; Yoshikawa, T, 2011) |
| "Carvedilol was initiated at a dose of 0." | 2.74 | Efficacy and safety of carvedilol for heart failure in children and patients with congenital heart disease. ( Ando, M; Hatai, Y; Mori, K; Murakami, Y; Nishiyama, M; Park, IS; Takahashi, Y; Yoshikawa, T, 2009) |
| "Hypertrophic cardiomyopathy is a complex and relatively common genetic disorder characterized by left ventricular (LV) hypertrophy, usually associated with a nondilated and hyperdynamic chamber with heterogeneous phenotypic expression and clinical course." | 1.39 | Two different cardiomyopathies in a single patient : hypertrophic cardiomyopathy and left ventricular noncompaction. ( Mutlu, B; Ozben, B; Sunbul, M, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (33.33) | 29.6817 |
| 2010's | 6 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bodi, I | 1 |
| Franke, G | 1 |
| Pantulu, ND | 1 |
| Wu, K | 1 |
| Perez-Feliz, S | 1 |
| Bode, C | 1 |
| Zehender, M | 1 |
| zur Hausen, A | 1 |
| Brunner, M | 1 |
| Odening, KE | 1 |
| Cho, MJ | 1 |
| Lim, RK | 1 |
| Jung Kwak, M | 1 |
| Park, KH | 1 |
| Kim, HY | 1 |
| Kim, YM | 1 |
| Lee, HD | 1 |
| Nishiyama, M | 1 |
| Park, IS | 2 |
| Yoshikawa, T | 2 |
| Hatai, Y | 1 |
| Ando, M | 2 |
| Takahashi, Y | 2 |
| Mori, K | 2 |
| Murakami, Y | 2 |
| Auerbach, SR | 1 |
| Richmond, ME | 1 |
| Lamour, JM | 1 |
| Blume, ED | 1 |
| Addonizio, LJ | 1 |
| Shaddy, RE | 1 |
| Mahony, L | 1 |
| Pahl, E | 1 |
| Hsu, DT | 1 |
| Lowenthal, A | 1 |
| Shah, A | 1 |
| Bernstein, HS | 1 |
| Ishibashi, N | 1 |
| Waragai, T | 1 |
| Mimori, S | 1 |
| Doi, S | 1 |
| Mizutani, S | 1 |
| Nakanishi, T | 1 |
| Sunbul, M | 1 |
| Ozben, B | 1 |
| Mutlu, B | 1 |
| Harada, T | 1 |
| Ohtaki, E | 1 |
| Kitahara, K | 1 |
| Sumiyoshi, T | 1 |
| Hosoda, S | 1 |
| Toyono, M | 1 |
| Kondo, C | 1 |
| Nakajima, Y | 1 |
| Nakazawa, M | 1 |
| Momma, K | 1 |
| Kusakabe, K | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Identification of Biomarkers for Heart Failure in Children With Single Ventricle Physiology[NCT00571233] | 71 participants (Actual) | Observational | 2007-02-28 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for carvedilol and Abnormality, Heart
| Article | Year |
|---|---|
Effects of beta-blockers for congestive heart failure in pediatric and congenital heart disease patients: a meta-analysis of published studies.
Topics: Adrenergic beta-Antagonists; Age Factors; Bisoprolol; Carbazoles; Carvedilol; Child; Heart Defects, | 2015 |
1 trial available for carvedilol and Abnormality, Heart
| Article | Year |
|---|---|
Efficacy and safety of carvedilol for heart failure in children and patients with congenital heart disease.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Carbazoles; Carvedilol; Child; Child, Preschool; Fem | 2009 |
7 other studies available for carvedilol and Abnormality, Heart
| Article | Year |
|---|---|
Differential effects of the β-adrenoceptor blockers carvedilol and metoprolol on SQT1- and SQT2-mutant channels.
Topics: Action Potentials; Adrenergic beta-Antagonists; Animals; Arrhythmias, Cardiac; Carbazoles; Carvedilo | 2013 |
BNP levels predict outcome in pediatric heart failure patients: post hoc analysis of the Pediatric Carvedilol Trial.
Topics: Adrenergic beta-Antagonists; Age Factors; Biomarkers; Carbazoles; Cardiomyopathies; Carvedilol; Chi- | 2010 |
Letter by Lowenthal et al regarding article, "BNP levels predict outcome in pediatric heart failure patients: post hoc analysis of the Pediatric Carvedilol Trial".
Topics: Adrenergic beta-Antagonists; Carbazoles; Carvedilol; Child; Child, Preschool; Clinical Trials as Top | 2010 |
Effect of carvedilol on heart failure in patients with a functionally univentricular heart.
Topics: Adolescent; Adrenergic alpha-1 Receptor Antagonists; Adult; Angiotensin-Converting Enzyme Inhibitors | 2011 |
Two different cardiomyopathies in a single patient : hypertrophic cardiomyopathy and left ventricular noncompaction.
Topics: Adrenergic beta-Antagonists; Adult; Anticoagulants; Carbazoles; Cardiomyopathy, Hypertrophic; Carved | 2013 |
Carvedilol-induced changes in cardiac diastolic performance in a patient with isolated noncompaction of the myocardium.
Topics: Adrenergic beta-Antagonists; Adult; Carbazoles; Cardiomyopathies; Carvedilol; Diastole; Echocardiogr | 2002 |
Effects of carvedilol on left ventricular function, mass, and scintigraphic findings in isolated left ventricular non-compaction.
Topics: 3-Iodobenzylguanidine; Adrenergic beta-Antagonists; Carbazoles; Carvedilol; Echocardiography; Fatty | 2001 |